Here are the S-3 shelf registrations from Carlsmed, Inc. (CARL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow CARL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CARL filings page.
Carlsmed, Inc., a Delaware-based medical technology company focused on AI-enabled personalized spine surgery solutions, has filed a shelf registration to offer up to $250,000,000 of common stock, preferred stock, debt securities, warrants and units from time to time. The filing allows Carlsmed to access capital markets in multiple tranches, with specific terms and pricing for each issuance to be detailed in future prospectus supplements.
The company’s aprevo Technology Platform provides customized spinal implants and single-use instruments manufactured via a digital production system with a typical six-business-day lead time from surgeon plan approval to hospital delivery. Carlsmed’s capital structure authorizes 600,000,000 shares of common stock and 10,000,000 shares of preferred stock, with no preferred shares currently outstanding as of June 30, 2026. Its common stock trades on the Nasdaq Global Select Market under the symbol CARL, and the last reported share price was $13.99 on August 13, 2026. The company highlights existing investor registration rights, anti-takeover and forum-selection provisions, and outlines generic terms under which future debt securities and warrants may be issued.